Real World Evidence
At Curaleaf Clinic, we use real-world patient experiences to improve care and publish research that advances understanding of medical cannabis.
UK Medical Cannabis Registry
We established the UK Medical Cannabis Registry, the largest patient registry dedicated to the study of medical cannabis in the UK, with approval from the Health Research Authority.
The Registry helps ensure medical cannabis is prescribed responsibly by collecting real-world information about treatments. This includes details about prescribed products, any side effects experienced, and patient-reported outcomes on health and wellbeing.
Patients from across the UK, with a wide range of conditions, can choose to take part by giving their consent.
Taking part is simple and secure, with the Curaleaf Clinic Online Account allowing patients to easily see and track their health progress over time.
For enquiries, please contact: [email protected]
The Curaleaf Access Scheme
Patients at Curaleaf Clinic who enrol on the Curaleaf Access Scheme can contribute directly to the UK Medical Cannabis Registry. Through this scheme UK medical cannabis patients can:
Receive significantly reduced appointment costs
Gain greater insight into how their medical cannabis is affecting them
Be part of advancing medical cannabis research
Publications
At Curaleaf Clinic we are passionate about medical cannabis research and proud to publish findings from the UK Medical Cannabis Registry in peer-reviewed journals. These papers are used to educate health care professionals and improve UK prescribing.
A big thank you to our patients who contribute to the Registry and make this all possible.
For more research from the wider industry please click here.
2025
2024
2023
2022
2021
Clinical Trials
At Curaleaf Clinic we understand the importance of generating high level evidence and allowing patients access to clinical trials.
As we are led by several prominent academic clinicians based at institutions, including Imperial College and Kings College, we are actively involved in this process.
We have therefore set up a clinical trials hub through which patients can access studies nationally and through which academia, industry, regulators, and funding bodies can deliver collaborative research projects aimed to generate the data necessary to inform public policy recommendations and support drug licensing.
The Curaleaf Clinical Trials hub is ideally suited as a vehicle to recruit patients for clinical trials ranging from early phase 1 to multi-national randomised controlled trials. We welcome partnerships with academia and industry to support generation of robust datasets, and we have the tools and infrastructure in place to deliver regulatory grade evidence using our real world data acquisition platform.
For further information please contact: [email protected]